LUSAKA, Zambia – Ensuring that Africa can manufacture its own vaccines will represent “the second independence of Africa”, Dr Jean Kaseya, Director General of the Africa Centre for Disease Control and Prevention (Africa CDC), said at the start of the Conference for Public Health in Africa 2023 (CPHIA) on Monday. “Many African countries got their […] Continue reading ->
A new Health Technology Access Pool (H-TAP), which aims to broaden the scope of IP and patent-sharing with low- and middle-income countries and a new African Union co-sponsored ‘manufacturing support platform’ were among the initiatives announced this week at the Second World Local Production forum in The Hague. The global forum, the second ever to […] Continue reading ->
Time-bound waivers of intellectual property (IP) rights and benefits for countries that share information about threatening pathogens are some of the key components of the draft pandemic accord  sent to World Health Organization (WHO) member states by the Intergovernmental Negotiating Body (INB) on Monday. These two issues have been major bones of contention in negotiations and […] Continue reading ->
BERLIN, Germany — Hours before the release of the second draft of the Pandemic Accord on Monday, German Health Minister Karl Lauterbach told the World Health Summit that a pandemic agreement with “major limitations” on intellectual property (IP)  rights protection will “not fly” for Germany and most of its fellow European Union (EU) members.  “For […] Continue reading ->
German Ministers urge more investment in the Pandemic Fund and universal health coverage at a high-level pandemic preparedness meeting  Even if vaccines and medicines are developed at record speed to address the next ominous global pathogen, they cannot prevent a pandemic without strong health systems to deliver them, stressed politicians and health leaders at a […] Continue reading ->
There are “concerning trends for COVID-19 ahead of the winter season in the northern hemisphere”, including increased ICU admissions and hospitalisation in Europe, and case increases in the Middle East and Asia, according to World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus. However, the WHO’s ability to assess the threat of new COVID-19 variants […] Continue reading ->
Pharmaceutical giant Janssen/Johnson & Johnson (J&J) and generic manufacturer Serum Institute of India (SII) charged the South African government more than the European Union for COVID-19 vaccines – and South Africa assumed all the risk in ‘take-it-or-leave-it’ contracts with Pfizer, J&J and SII. This is according to an analysis of the contracts led by Health […] Continue reading ->